Drugs / sFilm-FS
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04660721 | May 2021 → May 2023 | vascular hemostatic disease | Sealantium Medical Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sFilm-FS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04660721 ↗ |
| Modality | Protein / enzyme biologic | “sFilm-FS is a sterile bio-compatible bio-absorbable patch embedded with lyophilized powders of Human Fibrinogen, Human Thrombin and calcium chloride.” NCT04660721 ↗ |